InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53
United States Fiscal year ends December CIK 0001652130 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
John M Leonard
12 Dec 2025
President and CEO
Exercised, kept
8,557
$6.83
$58.44K
David Lebwohl
24 Sep 2021
EVP, Chief Medical Officer
Exercised, kept
7,923
$12.62
$99.99K
John M Leonard
13 Apr 2021
President and CEO
Exercised, kept
15,937
$13.88
$221.21K
John M Leonard
13 Apr 2021
President and CEO
Exercised, kept
10,000
$6.83
$68.30K
Fred E Cohen
20 Jan 2021
Director
Exercised, kept
20,000
$13.78
$275.60K
Andrew Schiermeier
30 Dec 2020
EVP, Chief Operating Officer
Exercised, kept
1,500
$13.48
$20.22K
Showing 250 of 298 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 289
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 158
Sales at will 115
Transactions with no price 1
Shares from compensation/vesting 4,470,192
Sales filed before the plan box existed 75
History held since 9 May 2016